JP2007518815A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518815A5
JP2007518815A5 JP2006551327A JP2006551327A JP2007518815A5 JP 2007518815 A5 JP2007518815 A5 JP 2007518815A5 JP 2006551327 A JP2006551327 A JP 2006551327A JP 2006551327 A JP2006551327 A JP 2006551327A JP 2007518815 A5 JP2007518815 A5 JP 2007518815A5
Authority
JP
Japan
Prior art keywords
composition
tenofovir
treating
dehobiru
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006551327A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007518815A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/002043 external-priority patent/WO2005072748A1/en
Publication of JP2007518815A publication Critical patent/JP2007518815A/ja
Publication of JP2007518815A5 publication Critical patent/JP2007518815A5/ja
Pending legal-status Critical Current

Links

JP2006551327A 2004-01-21 2005-01-21 乳癌および原発性胆汁性肝硬変に関与するmmtv様ウイルスを阻害するためのアデホビルまたはテノホビルの使用 Pending JP2007518815A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53806604P 2004-01-21 2004-01-21
PCT/US2005/002043 WO2005072748A1 (en) 2004-01-21 2005-01-21 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis

Publications (2)

Publication Number Publication Date
JP2007518815A JP2007518815A (ja) 2007-07-12
JP2007518815A5 true JP2007518815A5 (https=) 2008-03-13

Family

ID=34825960

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551327A Pending JP2007518815A (ja) 2004-01-21 2005-01-21 乳癌および原発性胆汁性肝硬変に関与するmmtv様ウイルスを阻害するためのアデホビルまたはテノホビルの使用

Country Status (10)

Country Link
US (2) US20070281911A1 (https=)
EP (1) EP1732569B1 (https=)
JP (1) JP2007518815A (https=)
AT (1) ATE445404T1 (https=)
AU (1) AU2005209256B2 (https=)
CA (1) CA2553455A1 (https=)
DE (1) DE602005017131D1 (https=)
ES (1) ES2334149T3 (https=)
NZ (1) NZ548532A (https=)
WO (1) WO2005072748A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006114064A2 (en) * 2005-04-25 2006-11-02 Institute Of Organic Chemistry And Biochemistry Ofthe Academy Of Sciences Of The Czech Republic Use of compounds to enhance processivity of telomerase
RU2301088C2 (ru) * 2005-09-01 2007-06-20 Ростовский научно-исследовательский онкологический институт МЗ РФ Способ лечения рецидива рака молочной железы
EP2020996B1 (en) 2006-05-16 2011-11-23 Gilead Sciences, Inc. Method and compositions for treating hematological malignancies
AU2010303628B2 (en) * 2009-10-05 2015-07-09 Ambergen, Inc. A method for diagnosing primary biliary cirrhosis (PBC) using novel autoantigens
US20140031250A1 (en) 2010-10-07 2014-01-30 David Tsai Ting Biomarkers of Cancer
EP4556010A3 (en) 2011-11-30 2025-07-23 Emory University Jak inhibitors for use in the prevention or treatment of a viral disease caused by a coronaviridae
US10301624B2 (en) 2014-06-25 2019-05-28 The General Hospital Corporation Targeting human satellite II (HSATII)
DK3236972T3 (en) 2014-12-26 2021-10-04 Univ Emory Antivirale N4-hydroxycytidin-derivativer
GB201509431D0 (en) * 2015-06-01 2015-07-15 Equigerminal Sa Antiviral composition
JP6804790B1 (ja) 2017-12-07 2020-12-23 エモリー ユニバーシティー N4−ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途
KR102196711B1 (ko) * 2018-08-30 2020-12-30 가톨릭대학교 산학협력단 테노포비르 디소프록실 푸마르산을 유효성분으로 함유하는, 간섬유증 예방 또는 치료용 약학적 조성물
JP7663236B2 (ja) * 2019-02-22 2025-04-16 一素 村田 mTOR阻害剤
EP3993873A4 (en) * 2019-07-02 2023-09-20 Virago Vax Inc. SUPPRESSION OF BREAST TUMORS
US12029783B2 (en) 2019-07-02 2024-07-09 Virago Vax Inc. Mammary tumor virus vaccine
US12016844B2 (en) 2019-07-02 2024-06-25 Virago Vax Inc. Mammary tumor virus suppression
TW202400134A (zh) 2022-03-15 2024-01-01 美商羅米醫療公司 用於治療疾病之化合物及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1220948B1 (en) * 1999-06-01 2008-05-14 Alton Ochsner Medical Foundation Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
CA2369848C (en) * 1999-06-30 2011-09-20 Robert F. Garry Human endogenous retrovirus in breast cancer
CZ304734B6 (cs) * 2000-07-21 2014-09-10 Gilead Sciences, Inc. Způsob přípravy 9-[2-(fosfonomethoxy)propyl]adeninu a 9-[2-(fosfonomethoxy)ethyl]adeninu
NZ536328A (en) * 2002-05-13 2007-11-30 Metabasis Therapeutics Inc Novel phosphonic acid based prodrugs of PMEA and its analogues

Similar Documents

Publication Publication Date Title
JP2007518815A5 (https=)
JP5763834B2 (ja) 置換2,3−ジヒドロイミダゾ[1,2−c]キナゾリン塩類
Douillard et al. Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation
CY1119865T1 (el) Φαρμακευτικες συνθεσεις για την αντιμετωπιση της νοσου του παρκινσον
JP2008530108A5 (https=)
ES2561495T3 (es) Régimen de tratamiento que utiliza neratinib contra cáncer de mama
JP2013543883A5 (https=)
WO2020163598A1 (en) Immunophilin-dependent inhibitors and uses thereof
JP2019524883A5 (https=)
JP2016006096A5 (https=)
JP2013516442A5 (https=)
JP2011529919A5 (https=)
TW200635923A (en) Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
RU2010151428A (ru) Пероральные составы, содержащие аналоги цитидина, и способы их использования
EP3802544A1 (en) Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses
JP2015536986A5 (https=)
JP2012522837A5 (https=)
JP2015524847A (ja) 小細胞肺がんを治療するためのベンゾジアゼピン
JP2015502926A5 (https=)
RU2015139225A (ru) Применение производных, содержащих связи с-о-р, у пациентов с почечной недостаточностью
JP2019501185A (ja) 食道癌を治療するためのキノリン誘導体の使用とその治療方法、医薬組成物及びキット
JP2020531463A5 (https=)
CN111818925A (zh) Cdk4/6抑制剂与egfr抑制剂联合在制备治疗肿瘤疾病的药物中的用途
JP2015117185A5 (https=)
JP2013511526A5 (https=)